Syndax Pharmaceuticals (SNDX) Financials

$18.18

$-0.64 (-3.40%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,623 Mln

Revenue (TTM)

$252 Mln

P/E Ratio

--

P/B Ratio

111.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	252.00	172.35	23.68	--	126.58	139.71
Cost of Revenue	6.37	6.97	0.83	0.01	0.45	0.46
Gross Profit	245.64	165.38	22.85	-0.01	-0.45	139.71
Operating Expenses	439.81	438.47	362.53	229.95	151.76	113.49
Operating Profit (EBIT)	-194.17	-273.08	-339.67	-229.95	-151.76	26.22
Other Income	--	--	--	--	--	0.61
Profit before Tax	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Provision for Tax	--	--	-318.76	--	-5.59	-0.04
Profit after Tax (Net Income)	-220.77	-285.42	-318.76	-209.36	-143.75	24.93
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-149.34	24.93

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	15.10	64.63	288.12	554.20	467.45	408.37
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	588.88	344.96	333.14	0.59	0.72	20.61
Current Liabilities	99.68	120.12	103.55	58.10	29.07	20.68
Total Liabilities	803.33	529.71	724.82	612.88	497.24	449.66

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	29.12	1.63	121.76	32.00	7.45	1.26
Current Assets	675.04	528.08	603.06	580.88	489.79	448.40
Total Assets	803.33	529.71	724.82	612.88	497.24	449.66
Total Debt*	589.38	346.48	345.74	1.64	1.16	20.97
Net Current Assets	575.36	407.97	499.51	522.78	460.72	427.71

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-322.98	-274.90	-160.60	-133.68	29.13
Cash Flow from Investing Activities	--	290.04	-219.78	117.61	-186.19	-40.87
Cash from Financing Activities	--	13.68	353.37	264.13	172.25	118.46
Net Cash Inflow / Outflow	--	--	--	--	--	106.72

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.53	-3.30	-3.72	-2.89	-2.27	0.47
Cash EPS ($)	-2.51	-3.29	-3.72	-2.89	-2.27	0.47
Adjusted Book Value ($)	0.17	0.75	3.36	7.64	7.40	7.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.73	-3.20	-2.21	-2.12	0.55
Free Cash Flow per Share ($)	--	-3.73	-3.20	-2.21	-2.12	0.55

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-54.63	-53.59	-40.87	-32.02	7.10
ROE (%)	-553.79	-161.82	-75.69	-40.98	-32.83	7.55
ROA (%)	-29.19	-45.50	-47.66	-37.72	-30.36	6.64
EBIT Margin (%)	-39.11	-146.00	-1,325.29	--	-119.89	18.77
Net Margin (%)	-87.60	-165.60	-1,346.11	--	-113.57	17.76
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	222.34	6.28	--	-1.00	-0.09	91.10
EBIT Growth (%)	70.78	19.82	-50.05	-37.82	-678.78	136.71
Net Profit Growth (%)	34.10	10.46	-52.25	-45.64	-676.70	134.11
EPS Growth (%)	35.13	0.11	-0.29	-0.27	-5.85	1.30
Book Value Growth (%)	-90.69	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-6.38	-3.56	-7.49	-11.19	46.70
Price / Book Value	111.30	28.16	3.94	2.83	3.44	2.85
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-105.26	-6.97	-2.86	-4.74	-7.41	28.11
Close Price ($)	21.86	21.01	13.22	21.61	25.45	21.89
High Price ($)	25.59	22.73	25.34	29.86	26.51	25.68
Low Price ($)	8.59	8.58	12.40	11.22	13.27	13.02
Market Cap ($ Cr)	1,623.42	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	38.95	5.36	1.20	0.00	0.00	0.05
Short term debt to equity ratio	0.03	0.01	0.04	0.00	0.00	0.00
Current Ratio	6.77	4.40	5.82	10.00	16.85	21.68
Quick Ratio	6.44	4.12	5.82	9.96	17.00	21.31
Interest Coverage	-1.58	-7.45	-63.67	-1,005.54	-48.38	13.81

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	27.84	40.78	58.58	--	3.21	0.31
Asset Turnover	0.33	0.27	0.04	--	0.27	0.37
Receivable days	--	89.18	116.44	--	6.47	0.79
Inventory Days	--	867.80	523.78	-34,211.75	1,367.68	5,179.98
Payable days	--	739.04	4,772.79	217,795.53	4,030.22	3,675.33
Cash Conversion Cycle	--	217.93	-4,132.58	--	-2,656.07	1,505.44

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.